CO2017013359A2 - Células madre derivadas de placenta, útiles para restaurar el motor regenerativo, corregir defectos proteómicos y ampliar la vida útil de sujetos envejecidos - Google Patents

Células madre derivadas de placenta, útiles para restaurar el motor regenerativo, corregir defectos proteómicos y ampliar la vida útil de sujetos envejecidos

Info

Publication number
CO2017013359A2
CO2017013359A2 CONC2017/0013359A CO2017013359A CO2017013359A2 CO 2017013359 A2 CO2017013359 A2 CO 2017013359A2 CO 2017013359 A CO2017013359 A CO 2017013359A CO 2017013359 A2 CO2017013359 A2 CO 2017013359A2
Authority
CO
Colombia
Prior art keywords
stem cells
subject
tissue
pdsc
over time
Prior art date
Application number
CONC2017/0013359A
Other languages
English (en)
Inventor
Robert J Hariri
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of CO2017013359A2 publication Critical patent/CO2017013359A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

La presente invención se refiere, en parte, al uso de células madre, tales como células madre derivadas de placenta (PDSC), para reducir los efectos del envejecimiento, por ejemplo, restaurar el motor regenerativo y prolongar la vida de los sujetos maduros. Se proporcionan en la presente, por ejemplo, métodos para mantener o aumentar la relación entre el número de células madre y el número de células diferenciadas en un tejido de un sujeto a lo largo del tiempo, que comprenden administrar al sujeto una cantidad efectiva de una población de células madre (p. ej. , PDSC), en donde la relación se mantiene o aumenta con el tiempo en comparación con la relación entre el número de células madre y el número de células diferenciadas en un tejido de un sujeto de control a lo largo del tiempo. Además, se proporcionan métodos para mantener o aumentar el número de células madre en un tejido de un sujeto a lo largo del tiempo, que comprenden administrar al sujeto una cantidad efectiva de una población de células madre (por ejemplo, PDSC), donde el número de células madre en el el tejido del sujeto se mantiene o aumenta con el tiempo en comparación con el número de células madre en el mismo tejido de un sujeto de control. También se proporcionan en este documento métodos para alterar el fenotipo o proteoma de un residente de células madre en envejecimiento en un tejido de un sujeto, que comprende administrar al sujeto una cantidad efectiva de una población de células madre (por ejemplo, PDSC), en donde la cantidad es efectiva para alterar el nicho ambiental de la célula madre envejecida de modo que el fenotipo o proteoma de la célula madre se altere en comparación con el fenotipo de la célula madre residente en el tejido de un sujeto de control.
CONC2017/0013359A 2015-05-28 2017-12-22 Células madre derivadas de placenta, útiles para restaurar el motor regenerativo, corregir defectos proteómicos y ampliar la vida útil de sujetos envejecidos CO2017013359A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562167786P 2015-05-28 2015-05-28
PCT/US2016/034773 WO2016191724A1 (en) 2015-05-28 2016-05-27 Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan

Publications (1)

Publication Number Publication Date
CO2017013359A2 true CO2017013359A2 (es) 2018-03-28

Family

ID=57393743

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0013359A CO2017013359A2 (es) 2015-05-28 2017-12-22 Células madre derivadas de placenta, útiles para restaurar el motor regenerativo, corregir defectos proteómicos y ampliar la vida útil de sujetos envejecidos

Country Status (16)

Country Link
US (1) US20160346333A1 (es)
EP (1) EP3302065A4 (es)
JP (3) JP2018520211A (es)
KR (2) KR20180019613A (es)
CN (1) CN107846903A (es)
AU (2) AU2016267672A1 (es)
BR (1) BR112017025586A2 (es)
CA (1) CA2987064A1 (es)
CO (1) CO2017013359A2 (es)
EA (1) EA201792602A1 (es)
IL (1) IL255920B2 (es)
MX (1) MX2017015145A (es)
NZ (1) NZ737474A (es)
SG (1) SG10201911206PA (es)
WO (1) WO2016191724A1 (es)
ZA (1) ZA201707905B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018236134A2 (en) * 2017-06-21 2018-12-27 Korea Research Institute Of Bioscience And Biotechnology METHOD AND KIT FOR THE DIAGNOSIS OF MUSCLE WEAK RELATED DISEASES USING A BLOOD BIOMARKER
EP3803415A1 (en) * 2018-06-04 2021-04-14 Avon Products, Inc. Protein biomarkers for identifying and treating aging skin and skin conditions
KR20200055979A (ko) 2018-11-14 2020-05-22 (주)아모레퍼시픽 피부 노화 모델의 제조방법, 그 방법에 의해 제조된 피부 노화 모델 및 그 피부 노화 모델을 이용한 항노화 물질의 스크리닝 방법
CN109355393A (zh) * 2018-12-12 2019-02-19 武汉凯德维斯生物技术有限公司 宫颈小细胞癌相关的hpv整合基因位点及其应用
CN109908323A (zh) * 2019-04-01 2019-06-21 李胜 一种促成人体骨髓干细胞再生和激活休眠干细胞的复方制品制作方法
CN110179827A (zh) * 2019-06-27 2019-08-30 北京三有利和泽生物科技有限公司 牙源性间充质干细胞的应用
TWI761837B (zh) * 2020-05-20 2022-04-21 國立中央大學 通用人類誘導多能性幹細胞及其生成方法
CN112129877B (zh) * 2020-09-24 2021-07-20 南京医科大学 精浆甘露糖-6-磷酸和新蝶呤检测作为特发性男性不育诊断标志物及其应用
CN118176292A (zh) * 2021-10-14 2024-06-11 北京干细胞与再生医学研究院 年轻化非多能性细胞及其制备方法和应用
WO2023090901A1 (ko) * 2021-11-18 2023-05-25 의료법인 성광의료재단 기계 학습을 이용한 세포 노화의 마커를 선별하는 방법, 세포 노화 바이오 마커, 및 이를 이용한 세놀리틱 제제를 스크리닝 하는 방법
WO2024085637A1 (ko) * 2022-10-18 2024-04-25 동국대학교 산학협력단 혈장 유래 단백질을 포함하는 노화 방지용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7611500A (en) * 1999-09-24 2001-04-24 Abt Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
KR20190104428A (ko) * 2005-12-29 2019-09-09 안트로제네시스 코포레이션 태반 줄기 세포 집단
CN104099290A (zh) * 2006-10-23 2014-10-15 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
CA2677679A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
SI2120977T1 (sl) * 2007-02-12 2014-01-31 Anthrogenesis Coroporation Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
US9962409B2 (en) * 2007-10-01 2018-05-08 Vestion, Inc. Therapy using cardiac stem cells and mesenchymal stem cells
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
ES2358146B1 (es) * 2009-10-22 2012-03-23 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.

Also Published As

Publication number Publication date
BR112017025586A2 (pt) 2018-08-07
IL255920B2 (en) 2024-05-01
WO2016191724A1 (en) 2016-12-01
US20160346333A1 (en) 2016-12-01
JP2023116745A (ja) 2023-08-22
NZ737474A (en) 2022-11-25
CA2987064A1 (en) 2016-12-01
AU2016267672A1 (en) 2017-12-21
CN107846903A (zh) 2018-03-27
ZA201707905B (en) 2018-11-28
SG10201911206PA (en) 2020-01-30
AU2021203074A1 (en) 2021-06-10
IL255920A (en) 2018-01-31
JP2018520211A (ja) 2018-07-26
KR20180019613A (ko) 2018-02-26
KR20230145509A (ko) 2023-10-17
MX2017015145A (es) 2018-08-01
JP2021165289A (ja) 2021-10-14
EA201792602A1 (ru) 2018-06-29
IL255920B1 (en) 2024-01-01
EP3302065A1 (en) 2018-04-11
EP3302065A4 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
CO2017013359A2 (es) Células madre derivadas de placenta, útiles para restaurar el motor regenerativo, corregir defectos proteómicos y ampliar la vida útil de sujetos envejecidos
UY37495A (es) Dinucleótidos cíclicos como agonistas de sting
CO2019000395A2 (es) Genes de mini–distrofina optimizados y casetes de expresión y su uso
BR112015020456A2 (pt) método para operar um veículo automotor eletrificado e meios para a sua implementação
ECSP17059343A (es) ARNi VARIANTE
CO2017003319A2 (es) Electrolito para celda electroquímica recargable
CO2017005391A2 (es) Composiciones de antibiótico
CL2020002915A1 (es) Composiciones para el tratamiento de condiciones de la piel
BR112016007577A2 (pt) estrutura de proteção de bateria
CL2017002729A1 (es) Proteína de unión a rgma y su uso
BR112015023987A2 (pt) creme dental de duas fases
AR113134A1 (es) Arni variante
BR112016010191A2 (pt) matriz de eluição e usos desta
AR093569A1 (es) Tensioactivos pulmonares reconstituidos
CL2020003444A1 (es) Cuerpo conformado basado en óxido de magnesio y carbonato de calcio y método para su preparación
CO2020010793A2 (es) Composiciones de virus adeno-asociado para restaurar la función del gen pah y métodos de uso de las mismas
BR112017011946A2 (pt) disposição de estabilizador
BR112018014905A2 (pt) método para determinar o envelhecimento de um meio de armazenamento eletroquímico
DOP2016000079A (es) Glicoproteinas recombinantes y sus usos
ES2514140B1 (es) Uso del inhibidor de sulfatasas esteroideas STX64 para el tratamiento del envejecimiento
BR112014031381B8 (pt) Material de catodo ativo de alta tensão e seu método de preparação, bateria secundária de lítio, bem como pacote e veículo elétrico que compreendem a dita bateria
BR112015003702A2 (pt) composição adequada para esgotar os folículos ovarianos em mamíferos fêmeas, e, métodos para induzir esgotamento de folículo ovariano em um mamífero fêmea, para reduzir a capacidade reprodutiva de um mamífero, para controlar o tamanho da população de uma população de mamíferos não humanos e para preparar uma composição.
AR099753A1 (es) Composición para su utilización como plasma de control anormal de la coagulación en ensayos in vitro
AR110871A1 (es) Proteínas de fusión de factor ix y métodos de fabricación y uso de las mismas
CO2018005176A2 (es) Procedimiento para la determinación asistida por ordenador de parámetros de un acumulador de energía electroquímico